Introduction Contract Clauses (1,121)

Introduction. The purpose of this AppLovin Corporation Executive Change in Control and Severance Plan (the "Plan") is to provide assurances of specified benefits to certain employees of the Company whose employment could be being involuntarily terminated other than for death, Disability, or Cause or voluntarily terminated for Good Reason under the circumstances described in the Plan. This Plan is an "employee welfare benefit plan," as defined in Section 3(1) of ERISA. This document is both the written... instrument under which the Plan is maintained and the required summary plan description for the Plan. View More

Introduction. The purpose of this AppLovin Corporation Executive Change in Control and Severance Plan (the "Plan") is to provide assurances of specified benefits to certain employees of the Company whose employment could be being involuntarily terminated other than for death, Disability, or Cause or voluntarily terminated for Good Reason under the circumstances described in the Plan. This Plan is an "employee welfare benefit plan," as defined in Section 3(1) of ERISA. This document is both the written... instrument under which the Plan is maintained and the required summary plan description for the Plan. View More

Introduction. SCE Recovery Funding LLC, a Delaware limited liability company (the "Issuer"), proposes to issue and sell $533,265,000 aggregate principal amount of its Senior Secured Recovery Bonds, Series 2022-A, (the "Bonds"), identified in Schedule I hereto. The Issuer and Southern California Edison Company, a California corporation and the Issuer's direct parent ("SCE"), hereby confirm their agreement with the several Underwriters (as defined below) as set forth herein. The term "Underwriters" as used... herein shall be deemed to mean the entity or several entities named in Schedule II hereto and any underwriter substituted as provided in Section 7 hereof and the term "Underwriter" shall be deemed to mean any one of such Underwriters. If the entity or entities listed in Schedule I hereto as representatives (the "Representatives") are the same as the entity or entities listed in Schedule II hereto, then the terms "Underwriters" and "Representatives", as used herein, shall each be deemed to refer to such entity or entities. All obligations of the Underwriters hereunder are several and not joint. If more than one entity is named in Schedule I hereto, any action under or in respect of this underwriting agreement ("Underwriting Agreement") may be taken by such entities jointly as the Representatives or by one of the entities acting on behalf of the Representatives and such action will be binding upon all the Underwriters. View More

Introduction. SCE Recovery Funding LLC, a Delaware limited liability company (the "Issuer"), proposes to issue and sell $533,265,000 aggregate principal amount of its Senior Secured Recovery Bonds, Series 2022-A, (the "Bonds"), identified in Schedule I hereto. The Issuer and Southern California Edison Company, a California corporation and the Issuer's direct parent ("SCE"), hereby confirm their agreement with the several Underwriters (as defined below) as set forth herein. The term "Underwriters" as used... herein shall be deemed to mean the entity or several entities named in Schedule II hereto and any underwriter substituted as provided in Section 7 hereof and the term "Underwriter" shall be deemed to mean any one of such Underwriters. If the entity or entities listed in Schedule I hereto as representatives (the "Representatives") are the same as the entity or entities listed in Schedule II hereto, then the terms "Underwriters" and "Representatives", as used herein, shall each be deemed to refer to such entity or entities. All obligations of the Underwriters hereunder are several and not joint. If more than one entity is named in Schedule I hereto, any action under or in respect of this underwriting agreement ("Underwriting Agreement") may be taken by such entities jointly as the Representatives or by one of the entities acting on behalf of the Representatives and such action will be binding upon all the Underwriters. View More

Introduction. The purpose of this Ignyta, Inc. Severance and Change in Control Severance Plan (the "Plan") is to provide assurances of specified severance benefits to eligible employees of the Company whose employment is subject to being involuntarily terminated by the Company other than for Cause or who resigns for Good Reason under the circumstances described in the Plan, including, but not limited to, following a Change in Control of the Company. The Company recognizes that the potential of a Change in... Control can be a distraction to employees and can cause such employees to consider alternative employment opportunities. The Plan is intended to (i) assure that the Company will have continued dedication and objectivity of key employees, notwithstanding the possibility, threat or occurrence of a Change in Control and (ii) provide such employees with an incentive to continue their employment and to motivate them to maximize the value of the Company prior to and following a Change in Control for the benefit of its stockholders. This Plan is an "employee welfare benefit plan," as defined in Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended. This document constitutes both the written instrument under which the Plan is maintained and the required summary plan description for the Plan. View More

Introduction. This Revance Therapeutics, Inc. Second Amended and Restated Executive Severance Benefit Plan (the "Plan") is established by Revance Therapeutics, Inc. (the "Company"). The Plan was originally adopted by the Board on December 17, 2013; became effective without further action on the IPO Date (as defined below)(the "Effective Date"); was amended by the Board on May 7, 2015 to clarify that the Plan applies to all stock awards, including without limitation stock options, restricted stock awards and... restricted stock units; and was amended by the Board again on February 16, 2017 to extend benefits to Senior Vice President-level and Vice President-level employees.The Plan provides for severance benefits to the Chief Executive Officer, other executive officers, senior vice presidents and vice presidents, and key employees of the Company designated by the Board. This document constitutes the Summary Plan Description for the Plan. View More

Introduction. The Company hereby adopts the Plan, effective as of April 1, 2018. The purpose of the Plan is to encourage performance and achieve retention of a select group of executive employees of GSI Technology, Inc. This document constitutes the written instrument under which the Plan is maintained.

Introduction. The purpose of this Ignyta, Inc. Severance and Change in Control Severance Plan (the "Plan") is to provide assurances of specified severance benefits to eligible employees of the Company whose employment is subject to being involuntarily terminated by the Company other than for Cause or who resigns for Good Reason under the circumstances described in the Plan, including, but not limited to, following a Change in Control of the Company. The Company recognizes that the potential of a Change in... Control can be a distraction to employees and can cause such employees to consider alternative employment opportunities. The Plan is intended to (i) assure that the Company will have continued dedication and objectivity of key employees, notwithstanding the possibility, threat or occurrence of a Change in Control and (ii) provide such employees with an incentive to continue their employment and to motivate them to maximize the value of the Company prior to and following a Change in Control for the benefit of its stockholders. This Plan is an "employee welfare benefit plan," as defined in Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended. This document constitutes both the written instrument under which the Plan is maintained and the required summary plan description for the Plan. View More

Introduction. This Revance Therapeutics, Inc. Second Amended and Restated Executive Severance Benefit Plan (the "Plan") is established by Revance Therapeutics, Inc. (the "Company"). The Plan was originally adopted by the Board on December 17, 2013; became effective without further action on the IPO Date (as defined below)(the "Effective Date"); was amended by the Board on May 7, 2015 to clarify that the Plan applies to all stock awards, including without limitation stock options, restricted stock awards and... restricted stock units; and was amended by the Board again on February 16, 2017 to extend benefits to Senior Vice President-level and Vice President-level employees.The Plan provides for severance benefits to the Chief Executive Officer, other executive officers, senior vice presidents and vice presidents, and key employees of the Company designated by the Board. This document constitutes the Summary Plan Description for the Plan. View More

Introduction. The Company hereby adopts the Plan, effective as of April 1, 2018. The purpose of the Plan is to encourage performance and achieve retention of a select group of executive employees of GSI Technology, Inc. This document constitutes the written instrument under which the Plan is maintained.